A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why?
ABSTRACT Group A Streptococcus (GAS) is a major cause of global infection-related morbidity and mortality. A modern controlled human infection model (CHIM) of GAS pharyngitis can accelerate vaccine development and pathogenesis research. A robust rationale for strain selection is central to meeting e...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f9d2f88500d34fb29810c3141be9b1b6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f9d2f88500d34fb29810c3141be9b1b6 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f9d2f88500d34fb29810c3141be9b1b62021-11-15T15:22:04ZA Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why?10.1128/mSphere.00647-182379-5042https://doaj.org/article/f9d2f88500d34fb29810c3141be9b1b62019-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00647-18https://doaj.org/toc/2379-5042ABSTRACT Group A Streptococcus (GAS) is a major cause of global infection-related morbidity and mortality. A modern controlled human infection model (CHIM) of GAS pharyngitis can accelerate vaccine development and pathogenesis research. A robust rationale for strain selection is central to meeting ethical, scientific, and regulatory requirements. Multifaceted characterization studies were done to compare a preferred candidate emm75 (M75) GAS strain to three other strains: an alternative candidate emm12 (M12) strain, an M1 strain used in 1970s pharyngitis CHIM studies (SS-496), and a representative (5448) of the globally disseminated M1T1 clone. A range of approaches were used to explore strain growth, adherence, invasion, delivery characteristics, short- and long-term viability, phylogeny, virulence factors, vaccine antigens, resistance to killing by human neutrophils, and lethality in a murine invasive model. The strains grew reliably in a medium without animal-derived components, were consistently transferred using a swab method simulating the CHIM protocol, remained viable at −80°C, and carried genes for most candidate vaccine antigens. Considering GAS molecular epidemiology, virulence factors, in vitro assays, and results from the murine model, the contemporary strains show a spectrum of virulence, with M75 appearing the least virulent and 5448 the most. The virulence profile of SS-496, used safely in 1970s CHIM studies, was similar to that of 5448 in the animal model and virulence gene carriage. The results of this multifaceted characterization confirm the M75 strain as an appropriate choice for initial deployment in the CHIM, with the aim of safely and successfully causing pharyngitis in healthy adult volunteers. IMPORTANCE GAS (Streptococcus pyogenes) is a leading global cause of infection-related morbidity and mortality. A modern CHIM of GAS pharyngitis could help to accelerate vaccine development and drive pathogenesis research. Challenge strain selection is critical to the safety and success of any CHIM and especially so for an organism such as GAS, with its wide strain diversity and potential to cause severe life-threatening acute infections (e.g., toxic shock syndrome and necrotizing fasciitis) and postinfectious complications (e.g., acute rheumatic fever, rheumatic heart disease, and acute poststreptococcal glomerulonephritis). In this paper, we outline the rationale for selecting an emm75 strain for initial use in a GAS pharyngitis CHIM in healthy adult volunteers, drawing on the findings of a broad characterization effort spanning molecular epidemiology, in vitro assays, whole-genome sequencing, and animal model studies.Joshua OsowickiKristy I. AzzopardiLiam McIntyreTania Rivera-HernandezCheryl-lynn Y. OngCiara BakerChristine M. GillenMark J. WalkerPierre R. SmeestersMark R. DaviesAndrew C. SteerAmerican Society for MicrobiologyarticleStreptococcus pyogenescontrolled human infection modelgroup A Streptococcushuman challenge studypharyngitisvaccinesMicrobiologyQR1-502ENmSphere, Vol 4, Iss 1 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Streptococcus pyogenes controlled human infection model group A Streptococcus human challenge study pharyngitis vaccines Microbiology QR1-502 |
| spellingShingle |
Streptococcus pyogenes controlled human infection model group A Streptococcus human challenge study pharyngitis vaccines Microbiology QR1-502 Joshua Osowicki Kristy I. Azzopardi Liam McIntyre Tania Rivera-Hernandez Cheryl-lynn Y. Ong Ciara Baker Christine M. Gillen Mark J. Walker Pierre R. Smeesters Mark R. Davies Andrew C. Steer A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why? |
| description |
ABSTRACT Group A Streptococcus (GAS) is a major cause of global infection-related morbidity and mortality. A modern controlled human infection model (CHIM) of GAS pharyngitis can accelerate vaccine development and pathogenesis research. A robust rationale for strain selection is central to meeting ethical, scientific, and regulatory requirements. Multifaceted characterization studies were done to compare a preferred candidate emm75 (M75) GAS strain to three other strains: an alternative candidate emm12 (M12) strain, an M1 strain used in 1970s pharyngitis CHIM studies (SS-496), and a representative (5448) of the globally disseminated M1T1 clone. A range of approaches were used to explore strain growth, adherence, invasion, delivery characteristics, short- and long-term viability, phylogeny, virulence factors, vaccine antigens, resistance to killing by human neutrophils, and lethality in a murine invasive model. The strains grew reliably in a medium without animal-derived components, were consistently transferred using a swab method simulating the CHIM protocol, remained viable at −80°C, and carried genes for most candidate vaccine antigens. Considering GAS molecular epidemiology, virulence factors, in vitro assays, and results from the murine model, the contemporary strains show a spectrum of virulence, with M75 appearing the least virulent and 5448 the most. The virulence profile of SS-496, used safely in 1970s CHIM studies, was similar to that of 5448 in the animal model and virulence gene carriage. The results of this multifaceted characterization confirm the M75 strain as an appropriate choice for initial deployment in the CHIM, with the aim of safely and successfully causing pharyngitis in healthy adult volunteers. IMPORTANCE GAS (Streptococcus pyogenes) is a leading global cause of infection-related morbidity and mortality. A modern CHIM of GAS pharyngitis could help to accelerate vaccine development and drive pathogenesis research. Challenge strain selection is critical to the safety and success of any CHIM and especially so for an organism such as GAS, with its wide strain diversity and potential to cause severe life-threatening acute infections (e.g., toxic shock syndrome and necrotizing fasciitis) and postinfectious complications (e.g., acute rheumatic fever, rheumatic heart disease, and acute poststreptococcal glomerulonephritis). In this paper, we outline the rationale for selecting an emm75 strain for initial use in a GAS pharyngitis CHIM in healthy adult volunteers, drawing on the findings of a broad characterization effort spanning molecular epidemiology, in vitro assays, whole-genome sequencing, and animal model studies. |
| format |
article |
| author |
Joshua Osowicki Kristy I. Azzopardi Liam McIntyre Tania Rivera-Hernandez Cheryl-lynn Y. Ong Ciara Baker Christine M. Gillen Mark J. Walker Pierre R. Smeesters Mark R. Davies Andrew C. Steer |
| author_facet |
Joshua Osowicki Kristy I. Azzopardi Liam McIntyre Tania Rivera-Hernandez Cheryl-lynn Y. Ong Ciara Baker Christine M. Gillen Mark J. Walker Pierre R. Smeesters Mark R. Davies Andrew C. Steer |
| author_sort |
Joshua Osowicki |
| title |
A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why? |
| title_short |
A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why? |
| title_full |
A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why? |
| title_fullStr |
A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why? |
| title_full_unstemmed |
A Controlled Human Infection Model of Group A <italic toggle="yes">Streptococcus</italic> Pharyngitis: Which Strain and Why? |
| title_sort |
controlled human infection model of group a <italic toggle="yes">streptococcus</italic> pharyngitis: which strain and why? |
| publisher |
American Society for Microbiology |
| publishDate |
2019 |
| url |
https://doaj.org/article/f9d2f88500d34fb29810c3141be9b1b6 |
| work_keys_str_mv |
AT joshuaosowicki acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT kristyiazzopardi acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT liammcintyre acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT taniariverahernandez acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT cheryllynnyong acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT ciarabaker acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT christinemgillen acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT markjwalker acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT pierrersmeesters acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT markrdavies acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT andrewcsteer acontrolledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT joshuaosowicki controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT kristyiazzopardi controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT liammcintyre controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT taniariverahernandez controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT cheryllynnyong controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT ciarabaker controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT christinemgillen controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT markjwalker controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT pierrersmeesters controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT markrdavies controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy AT andrewcsteer controlledhumaninfectionmodelofgroupaitalictoggleyesstreptococcusitalicpharyngitiswhichstrainandwhy |
| _version_ |
1718428106846371840 |